Replies to post #113944 on Anavex Life Sciences Corp (AVXL)

[nidan7500]

Little DD shows outline of talk. Sounds similar to previous talks by him. If lunch time in Melbourne then time in NYC?

Aug 09, 2017
Note This Is A Wednesday Luncheon Meeting

Breakthrough?
New Treatment Approaches in Alzheimer’s Disease
Currently available Alzheimer’s treatments are of limited benefit. With the number of cases worldwide expected to triple in the next 30 years, there is an urgent need to find treatments that treat the cause of the disease, rather than just mask the symptoms. Steve Macfarlane has been running Alzheimer’s trials for almost 20 years, including a Melbourne-based study of a new drug, Anavex 2-73, in which patients have shown signs of significant benefit
‘When Melbourne was selected as the first city in the world to test Anavex a year ago, lead researcher Associate Professor Steve Macfarlane had no idea how much of an impact it would make.
‘……seem to be significantly improved in terms of what they can do. It is function that has improved and in many cases mood as well,” Prof Macfarlane said.
‘To me, seeing real improvements to patients is much more important than seeing a statistically significant improvement on a rating scale’. (news.com.au)
Chair:  David Rosback

[mrplmer]

Public, accurate, and timely.

[bas2020]

If a PR is being planned before the AU Rotary presentation, then it will have to come by the AH on Tuesday. If none, then we shouldn't expect anything materially new to be presented.